These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9667968)

  • 1. Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonists.
    Edwards JP; Zhi L; Pooley CL; Tegley CM; West SJ; Wang MW; Gottardis MM; Pathirana C; Schrader WT; Jones TK
    J Med Chem; 1998 Jul; 41(15):2779-85. PubMed ID: 9667968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.
    Tegley CM; Zhi L; Marschke KB; Gottardis MM; Yang Q; Jones TK
    J Med Chem; 1998 Oct; 41(22):4354-9. PubMed ID: 9784110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.
    Edwards JP; West SJ; Marschke KB; Mais DE; Gottardis MM; Jones TK
    J Med Chem; 1998 Jan; 41(3):303-10. PubMed ID: 9464361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.
    Zhi L; Tegley CM; Kallel EA; Marschke KB; Mais DE; Gottardis MM; Jones TK
    J Med Chem; 1998 Jan; 41(3):291-302. PubMed ID: 9464360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
    Zhi L; Tegley CM; Pio B; Edwards JP; Motamedi M; Jones TK; Marschke KB; Mais DE; Risek B; Schrader WT
    J Med Chem; 2003 Sep; 46(19):4104-12. PubMed ID: 12954062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore.
    Pooley CL; Edwards JP; Goldman ME; Wang MW; Marschke KB; Crombie DL; Jones TK
    J Med Chem; 1998 Aug; 41(18):3461-6. PubMed ID: 9719599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tissue-selective nonsteroidal progesterone receptor modulator: 7,9-difluoro-5-(3-methylcyclohex-2-enyl)-2,2,4-trimethyl-1,2-dihydrochromeno[3,4-f]quinoline.
    Pedram B; van Oeveren A; Mais DE; Marschke KB; Verbost PM; Groen MB; Zhi L
    J Med Chem; 2008 Jul; 51(13):3696-9. PubMed ID: 18553958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.
    Hudson AR; Roach SL; Higuchi RI; Phillips DP; Bissonnette RP; Lamph WW; Yen J; Li Y; Adams ME; Valdez LJ; Vassar A; Cuervo C; Kallel EA; Gharbaoui CJ; Mais DE; Miner JN; Marschke KB; Rungta D; Negro-Vilar A; Zhi L
    J Med Chem; 2007 Sep; 50(19):4699-709. PubMed ID: 17705362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
    Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
    Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
    Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
    Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists.
    Thompson SK; Washburn DG; Frazee JS; Madauss KP; Hoang TH; Lapinski L; Grygielko ET; Glace LE; Trizna W; Williams SP; Duraiswami C; Bray JD; Laping NJ
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4777-80. PubMed ID: 19595590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
    Zhang P; Terefenko E; Kern J; Fensome A; Trybulski E; Unwalla R; Wrobel J; Lockhead S; Zhu Y; Cohen J; Lacava M; Winneker RC; Zhang Z
    Bioorg Med Chem; 2007 Oct; 15(20):6556-64. PubMed ID: 17681796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
    Kym PR; Kort ME; Coghlan MJ; Moore JL; Tang R; Ratajczyk JD; Larson DP; Elmore SW; Pratt JK; Stashko MA; Falls HD; Lin CW; Nakane M; Miller L; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Nguyen P; Lane BC
    J Med Chem; 2003 Mar; 46(6):1016-30. PubMed ID: 12620078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.
    Zhi L; Tegley CM; Marschke KB; Mais DE; Jones TK
    J Med Chem; 1999 Apr; 42(8):1466-72. PubMed ID: 10212133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrinological properties of two novel nonsteroidal progesterone receptor modulators, CP8816 and CP8863.
    Kurata Y; Tabata Y; Shinei R; Iizuka Y; Masuda NT; Kurihara K; Okonogi T; Hoshiko S
    J Pharmacol Exp Ther; 2005 May; 313(2):916-20. PubMed ID: 15743919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators.
    Zhi L; Tegley CM; Pio B; Edwards JP; Jones TK; Marschke KB; Mais DE; Risek B; Schrader WT
    Bioorg Med Chem Lett; 2003 Jun; 13(12):2071-4. PubMed ID: 12781197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A; Bender R; Chopra R; Cohen J; Collins MA; Hudak V; Malakian K; Lockhead S; Olland A; Svenson K; Terefenko EA; Unwalla RJ; Wilhelm JM; Wolfrom S; Zhu Y; Zhang Z; Zhang P; Winneker RC; Wrobel J
    J Med Chem; 2005 Aug; 48(16):5092-5. PubMed ID: 16078826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
    Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
    J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural comparisons of isomeric series of 7-aryl-benzo[h]pyrazolo[3,4-b]quinolines and 11-aryl-benzo[f]pyrazolo[3,4-b]quinolines.
    Portilla J; Quiroga J; Nogueras M; de la Torre JM; Cobo J; Low JN; Glidewell C
    Acta Crystallogr B; 2008 Feb; 64(Pt 1):72-83. PubMed ID: 18204214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.